Vical   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (1987)
Status: Acquired by Brickell Biotech, Inc. (2019)

Organization Overview

First Clinical Trial
1998
NCT00003647
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Mergers & Acquisitions

Historical Acquisition Tree